Bullish option flow detected in Ardelyx with 4,247 calls trading, 4x expected, and implied vol increasing over 2 points to 76.89%. Jan-24 7.5 calls and Dec-23 5 calls are the most active options, with total volume in those strikes near 1,100 contracts. The Put/Call Ratio is 0.02. Earnings are expected on February 29th.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on ARDX:
- Ardelyx, Inc. Reports Employment Inducement Grants
- Ardelyx to Participate at the Piper Sandler 35th Annual Healthcare Conference
- FDA grants Ardelyx ODD for XPHOZAH or tenapanor for Pediatric Hyperphosphate
- XPHOZAH® (tenapanor) Granted Orphan Drug Designation by U.S. FDA for the Treatment of Pediatric Hyperphosphatemia
- Ardelyx treatment of pediatric hyperphosphatemia granted orphan status